NMR spectroscopy in pharmacy
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 17 (4-5), 557-616
- https://doi.org/10.1016/s0731-7085(97)00276-8
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Application of the one-dimensional TOCSY pulse sequence in 750 MHz 1H-NMR spectroscopy for assignment of endogenous metabolite resonances in biofluidsJournal of Pharmaceutical and Biomedical Analysis, 1994
- Determination of enantiomeric purity of nicotine in pharmaceutical preparations by 13C-NMR in the presence of a chiral lanthanide shift reagentJournal of Pharmaceutical and Biomedical Analysis, 1994
- Analysis of biological fluids using 600 MHz proton NMR spectroscopy: Application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignmentJournal of Pharmaceutical and Biomedical Analysis, 1993
- Determination of chlorpheniramine maleate in tablets and injections by 1H-NMR spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 1993
- 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: Effects of sample manipulation and assignment of resonancesJournal of Pharmaceutical and Biomedical Analysis, 1993
- 750 MHz 1H-NMR spectroscopy of human blood plasmaJournal of Pharmaceutical and Biomedical Analysis, 1993
- HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by β-cyclodextrinJournal of Pharmaceutical and Biomedical Analysis, 1991
- 19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: Application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid]Journal of Pharmaceutical and Biomedical Analysis, 1990
- A study of flucloxacillin metabolites in rat urine by two-dimensional 1H, 19F COSY NMRJournal of Pharmaceutical and Biomedical Analysis, 1989
- Application of fluorine-19 nuclear magnetic resonance to the determination of plasma-protein binding of 5′-deoxy-5-fluorouridine, a new antineoplastic fluoropyrimidineJournal of Pharmaceutical and Biomedical Analysis, 1988